The efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 6, 2014, Pages 1171-1176

  Oh, Dong Hyun ^a   Lee, Dong Ho ^a   Kang, Kyu Keun ^a   Park, Young Soo ^a   Shin, Cheol Min ^a   Kim, Nayoung ^a   Yoon, Hyuk ^a   Hwang, Jin Hyeok ^a   Jeoung, Sook Hyang ^a   Kim, Jin Wook ^a   Jang, Eun Sun ^a   Jung, Hyun Chae ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Alternative therapies; Disease eradication; Helicobacter pylori; Hybrid therapy; Sequential therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; RABEPRAZOLE;

ADULT; ANOREXIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; BACTERIUM DETECTION; BITTER TASTE; CLINICAL EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DUODENUM ULCER; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYBRID ANTIBIOTIC THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MYALGIA; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RAPID UREASE TEST; SEQUENTIAL ANTIBIOTIC THERAPY; STOMACH ULCER; TREATMENT DURATION; UREA BREATH TEST; XEROSTOMIA; AGED; COMPARATIVE STUDY; DRUG COMBINATION; GASTRITIS; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

AGED; AMOXICILLIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; RABEPRAZOLE; TREATMENT OUTCOME;

EID: 84900545674     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12518     Document Type: Article

References (33)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
2. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol. Clin. North Am. 2000; 29: 559-578.
3. Blaser MJ. Helicobacter pylori and gastric diseases. BMJ 1998; 316: 1507-1510.
4. Suerbaum S, Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 2002; 347: 1175-1186.
5. McColl KE. Clinical practice. Helicobacter pylori infection. N. Engl. J. Med. 2010; 362: 1597-1604.
6. Malfertheiner P, Megraud F, O'Morain CA etal. Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664.
7. Fock KM, Katelaris P, Sugano K etal. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2009; 24: 1587-1600.
8. Kim SG, Jung HK, Lee HL etal. Guidelines for the diagnosis and treatment of Helicobacter pylori INFECTION in Korea, 2013 revised edition. Korean J. Gastroenterol. 2013; 62: 3-26.
9. Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter 2007; 12: 275-278.
10. Oh HS, Lee DH, Seo JY etal. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. J. Gastroenterol. Hepatol. 2012; 27: 504-509.
11. Cho DK, Park SY, Kee WJ etal. The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy. Korean J. Gastroenterol. 2010; 55: 368-375.
12. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384.
13. Lee JW, Kim N, Kim JM etal. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2013; 18: 206-214.
14. Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008; 5: 321-331.
15. Gisbert JP, Calvet X, O'Connor A, Mégraud F, O'Morain CA. Sequential therapy for Helicobacter pylori eradication: a critical review. J. Clin. Gastroenterol. 2010; 44: 313-325.
16. Gisbert JP, Calvet X. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Aliment. Pharmacol. Ther. 2011; 34: 604-617.
17. Zullo A, Rinaldi V, Winn S etal. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 2000; 14: 715-718.
18. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007; 56: 1353-1357.
19. Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am. J. Gastroenterol. 2009; 104: 3069-3079.
20. Yoon H, Lee DH, Kim N etal. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults? J. Gastroenterol. Hepatol. 2013; 28: 1801-1809.
21. Choi WH, Park DI, Oh SJ etal. Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea. Korean J. Gastroenterol. 2008; 51: 280-284.
22. Kwon JH, Lee DH, Song BJ etal. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study. Helicobacter 2010; 15: 148-153.
23. Park HG, Jung MK, Jung JT etal. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients. Aliment. Pharmacol. Ther. 2012; 35: 56-65.
24. Hsu PI, Wu DC, Wu JY, Graham DY. Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter 2011; 16: 139-145.
25. Sardarian H, Fakheri H, Hosseini V, Taqhvaei T, Maleki I, Mokhtare M. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial. Helicobacter 2013; 18: 129-134.
26. Murakami K, Fujioka T, Okimoto T, Sato R, Kodama M, Nasu M. Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. Int. J. Antimicrob. Agents 2002; 19: 67-70.
27. Kim JI, Kim BW. Sequential therapy of Helicobacter pylori infection. Korean J. Helicobacter Up. Gastrointest. Res. 2011; 11: 103-111.
28. Lim JH, Lee DH, Choi C etal. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Helicobacter 2013; 18: 180-186.
29. Zullo A, Scaccianoce G, De Francesco V etal. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study. Clin. Res. Hepatol. Gastroenterol. 2013; 37: 647-650.
30. Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS. Diagnosis and treatment guidelines for helicobacter pylori infection in Korea. Korean J. Gastroenterol. 2009; 54: 269-278.
31. Gisbert JP, Molina-Infante J, Marin AC, Vinaqre G, Barrio J, McNicholl AG. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection. Scand. J. Gastroenterol. 2013; 48: 652-656.
32. Zullo A, Hassan C, D'Ercole C, De Francesco V, Vaira D. Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? Aliment. Pharmacol. Ther. 2010; 31: 1248-1249; author reply 1249-50.
33. Zullo A, Hassan C, Lorenzetti R, Winn S, Morini S. A clinical practice viewpoint: to culture or not to culture Helicobacter pylori? Dig. Liver Dis. 2003; 35: 357-361.